Warning Letter Roundup: FDA Targets Firms for GMP, Other Violations By Sam | January 17, 2018 The FDA issued warning letters to eight drug manufacturers for adulterated products, misbranding and unapproved drug products, among other violations. Source: Drug GMP Report Posted in Drug GMP Report